Radiopharm Theranostics Limited - Sponsored ADR RADX
1.65
0.08
5.10%
as of 25 Sep
- Market cap
- $24.7M
- P/E
- —
Follow RADX
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Dec '25 | Jun '26 | |
|---|---|---|
Net Income |
(56.28) | (24.83) |
Other operating activities |
1.40 | (44.13) |
Operating Cash Flow |
(68.16) | (88.91) |
Other investing activities |
— | (4.07) |
Investing cash flow |
(0.39) | (4.07) |
Other financial activities |
(11.57) | (11.64) |
Financing cash flow |
94.81 | 97.87 |
Exchange Rate Adjustment |
0.24 | 0.16 |
Change in Cash |
26.52 | 5.05 |
Beginning Cash |
50.92 | 63.01 |
Ending Cash |
77.43 | 68.06 |
Dividends Paid (Common) |
0.00 | 0.00 |
Issuance/Purchase of Shares |
107.41 | 111.98 |
In millions of $ except per-share values · columns are period end dates